DR. PABLO MENÉNDEZ
Campus Clínic-UB Coordinator
He graduated in biochemistry and as Doctor of Medicine at the University of Salamanca. His scientific interests lie in the field of hematology/oncology and the transplant of cells and hematopoietic progenitors. He is a specialist in the etiology and pathogenesis of pediatric leukaemia.
In September 2013 he was appointed research director of the Clínic-UB Campus of the Josep Carreras Institute. He was previously trained with Prof. Mick Bhatia at the McMaster Cancer and Stem Cell Biology Research Institute in Toronto and at the Institute of Cancer Research in London together with Prof. Mel Greaves; and he was the director of the Andalusia Stem-cell Bank in Granada and chief researcher at GENyO (Pfizer—University of Granada—Junta of Andalusia Genome and Cancer Research Centre).
Dr. Pablo Menéndez was awarded the triennial ED Thomas Post-Doctoral Fellowship Grant by the Josep Carreras Foundation in 2006 and is currently professor at the Catalan Institution for Research and Advanced Studies, Generalitat de Catalunya. In 2015 his work was recognized with a grant from the European Research Council (ERC).
He has participated in more than 130 articles and has accumulated an impact factor of 1,040 and a factor H-index of 41.
DR. FRANCESC SOLÉ
Campus ICO-Germans Trias i Pujol Coordinator
An eminent biologist specialised in the genetic diagnosis of hematological neoplasms. He joined the Josep Carreras Leukemia Research Institute on 1 October 2012 to coordinate the IJC Catalan Institute for Oncology/Germans Trias i Pujol Campus, the line of research being focused on the study of myelodysplastic syndromes (MDS) and the centre’s cytogenetic and microarray platform.
Previously he was the head of the Cytogenetic and Molecular Biology Laboratory of the Hospital del Mar Pathology Service in Barcelona, amongst other posts. At the present time he is president of the Spanish myelodysplastic syndromes group and member of the Experts Committee of the Internationa Working Group for the Prognosis of MDS.
Over recent years he has been working on, and optimising, cytogenetic techniques and he was in charge of standardising in situ hybridisation techniques (FISH), molecular biology and sequencing as applied, mainly, to the diagnosis of hematological
He has published more than 280 articles, with an H-index of 34, and has accumulated an impact factor of 862. His work has been cited in 3,655 articles.
DR. JAVIER BRIONES
Campus Sant Pau Coordinator
Dr. Briones graduated in Medicine and Surgery from the University of Santiago with Hematology and Hemotherapy specialization (MIR) in the Hematology Service of the Hospital Clinic of Barcelona. He is Doctor of Medicine from the University of Barcelona. He did a postdoctoral stay at Stanford University (USA), in the laboratory of Dr. Ron Levy, where he developed projects on cellular vaccines and Gene therapy in lymphoma (1999-2001).
Currently Dr. Briones is Associate Professor of Medicine (Hematology) at the Autonomous University of Barcelona, Head of the Clinical Hematology Unit of the Hospital Santa Creu i Sant Pau (Barcelona), Director of the Immunotherapy Program Cellular in Hematological Neoplasms and PI of several national and International in CART cells. His research group develops CARs academic for the treatment of lymphoid neoplasms, the first of which (HSP- CAR30) has been authorized by the Spanish Medicines Agency (trial CART30 for Hodgkin's lymphoma). Dr. Briones is also the Sant Pau Campus Coordinator at Josep Carreras Leukaemia Research Institute.